Rothfuss Cristin (CIK 2046214) reported 8 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Sell SRPT (22,025 shares), Sell SRPT (974 shares), Sell SRPT (484 shares), Sell SRPT (346 shares), Sell SRPT (408 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Sell | 22,025 | $489,396 |
| 2026-03-13 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Sell | 974 | $16,587 |
| 2026-03-11 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Sell | 484 | $8,204 |
| 2026-03-11 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Sell | 346 | $5,865 |
| 2026-03-03 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Sell | 408 | $6,610 |
| 2025-12-02 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Sell | 229 | $4,836 |
| 2025-09-05 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Buy | 93,875 | $0 |
| 2025-09-05 | Sarepta Therapeutics, Inc. (SRPT) | EVP, General Counsel | Buy | 25,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08